Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1/2 13Phase 1 13Phase NA 2Phase EARLY_PHASE1 2Phase 3 1Phase 2/3 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Glioblastoma 17Glioma 15Breast Neoplasms 14Prostatic Neoplasms 13Neoplasms 13Brain Neoplasms 11Pancreatic Neoplasms 10Colorectal Neoplasms 10Neoplasm Metastasis 9Multiple Myeloma 8Lymphoma, B-Cell 8Recurrence 7Melanoma 7Lymphoma 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Lung Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3

Interventions

N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Hyperbaric Oxygenation 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia, Myelomonocytic, Chronic × 90 days × Clear all
NCT03964506 2026-06-03

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

University of Rochester

Phase EARLY_PHASE1 Recruiting
24 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT07071155 2026-03-27

M-HArbOr

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Recruiting
18 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡